ES2179667T3 - Nuevas formulaciones inyectables que contienen ramoplanina. - Google Patents
Nuevas formulaciones inyectables que contienen ramoplanina.Info
- Publication number
- ES2179667T3 ES2179667T3 ES99938289T ES99938289T ES2179667T3 ES 2179667 T3 ES2179667 T3 ES 2179667T3 ES 99938289 T ES99938289 T ES 99938289T ES 99938289 T ES99938289 T ES 99938289T ES 2179667 T3 ES2179667 T3 ES 2179667T3
- Authority
- ES
- Spain
- Prior art keywords
- ramoplanin
- injectable formulations
- formulations containing
- new injectable
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formulación farmacéutica para administración intravenosa que comprende ramoplanina o un miembro de la familia de la ramoplanina de fórmula I FÓRMULA I En la que R representa -CO-CH=CH-CH=CH-CH2-CH2-CH3, -CO-CH=CH-CH=CH-CH2-CH(CH3)2, -CO-CH=CH-CH=CH-CH2-CH2-CH(CH3)2, -CO-CH2-CH2-CH2-CH2-CH2-CH2-CH3, -CO-CH2-CH2-CH2-CH2-CH2-CH(CH3)2, ó -CO-CH2-CH2-CH2-CH2-CH2-CH2-CH(CH3)2 R¿ representa alfa-D-manopiranosilo o 2-O-alfa-D- manopiranosil-alfa-D-manopiranosilo, o R¿ representa 2,3-O-di[alfa-D-manopiranosil]-D- manopiranosilo, en la que R representa -CO-CH=CH-CH=CH-CH2- CH(CH3)2, una de sus sales de adición de ácido farmacéuticamente aceptable, o una mezcla de las mismas en cualquier proporción, mezclada con una cantidad de producto en emulsión grasa para administración intravenosa, en la que la concentración de la fase oleosa es al menos de un 0,2% (peso/volumen).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98114368A EP0976394A1 (en) | 1998-07-30 | 1998-07-30 | New injectable formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2179667T3 true ES2179667T3 (es) | 2003-01-16 |
Family
ID=8232378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99938289T Expired - Lifetime ES2179667T3 (es) | 1998-07-30 | 1999-07-19 | Nuevas formulaciones inyectables que contienen ramoplanina. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6720305B1 (es) |
EP (2) | EP0976394A1 (es) |
JP (1) | JP2002521422A (es) |
AT (1) | ATE223700T1 (es) |
AU (1) | AU5284999A (es) |
CA (1) | CA2332526A1 (es) |
DE (1) | DE69902925T2 (es) |
DK (1) | DK1100463T3 (es) |
ES (1) | ES2179667T3 (es) |
PT (1) | PT1100463E (es) |
WO (1) | WO2000006119A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0651677B1 (en) * | 1992-07-08 | 1997-10-01 | Nordson Corporation | Apparatus and methods for applying discrete foam coatings |
EP0579012B1 (en) * | 1992-07-08 | 1998-04-01 | Nordson Corporation | Apparatus and methods for applying discrete coatings |
CA2476567A1 (en) | 2002-03-08 | 2003-09-18 | Vicuron Pharmaceuticals Inc. | A process for the production of ramoplanin-like amide derivatives |
EP1994938A1 (en) * | 2007-05-21 | 2008-11-26 | Combinature Biopharm AG | New lipoglycodepsipeptide compositions |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2045231B (en) * | 1979-04-07 | 1983-08-03 | Lepetit Spa | Antibiotic a/16686 and its preparation from actinoplanes |
US5916588A (en) * | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
GB8727807D0 (en) * | 1987-11-27 | 1987-12-31 | Lepetit Spa | Novel antibiotic compounds named a/16686 factors a'1,a'2 and a'3 |
GB8729989D0 (en) * | 1987-12-23 | 1988-02-03 | Lepetit Spa | Novel hydrogenated derivatives of antibiotic a/16686 |
CA1326995C (en) * | 1988-01-29 | 1994-02-15 | Kozo Kurihara | Cyclosporin compositions |
GB8808658D0 (en) * | 1988-04-13 | 1988-05-18 | Lepetit Spa | Aglycons of a/16686 antibiotics |
US5225212A (en) * | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
DK0580778T3 (da) * | 1991-04-19 | 2000-01-31 | Lds Technologies Inc | Konvertible mikroemulsionsformuleringer |
US5688761A (en) * | 1991-04-19 | 1997-11-18 | Lds Technologies, Inc. | Convertible microemulsion formulations |
DE1118326T1 (de) * | 1993-05-21 | 2002-04-18 | Liposome Co Inc | Reduzierung von durch Liposomen induzierten physiologischen Gegenreaktionen |
US20020099067A1 (en) * | 1993-07-08 | 2002-07-25 | Ulrich Posanski | Pharmaceutical compositions for sparingly soluble therapeutic agents |
US5514670A (en) * | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
AU681761B2 (en) * | 1994-02-15 | 1997-09-04 | Biosearch Italia S.P.A. | Central venous catheters loaded with antibiotics of the ramoplanin group preventing development of catheter related infections |
US5891846A (en) * | 1994-02-17 | 1999-04-06 | Shiseido Company, Ltd. | Cyclosporin-containing emulsion composition |
EP0803255A4 (en) * | 1994-06-03 | 1999-06-30 | Tsumura & Co | DRUG |
US5885613A (en) * | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
-
1998
- 1998-07-30 EP EP98114368A patent/EP0976394A1/en not_active Withdrawn
-
1999
- 1999-07-19 JP JP2000561976A patent/JP2002521422A/ja not_active Withdrawn
- 1999-07-19 ES ES99938289T patent/ES2179667T3/es not_active Expired - Lifetime
- 1999-07-19 CA CA002332526A patent/CA2332526A1/en not_active Abandoned
- 1999-07-19 US US09/744,247 patent/US6720305B1/en not_active Expired - Lifetime
- 1999-07-19 AU AU52849/99A patent/AU5284999A/en not_active Abandoned
- 1999-07-19 EP EP99938289A patent/EP1100463B1/en not_active Expired - Lifetime
- 1999-07-19 DK DK99938289T patent/DK1100463T3/da active
- 1999-07-19 WO PCT/EP1999/005137 patent/WO2000006119A1/en active IP Right Grant
- 1999-07-19 DE DE69902925T patent/DE69902925T2/de not_active Expired - Fee Related
- 1999-07-19 PT PT99938289T patent/PT1100463E/pt unknown
- 1999-07-19 AT AT99938289T patent/ATE223700T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5284999A (en) | 2000-02-21 |
DE69902925D1 (de) | 2002-10-17 |
ATE223700T1 (de) | 2002-09-15 |
WO2000006119A1 (en) | 2000-02-10 |
PT1100463E (pt) | 2002-12-31 |
CA2332526A1 (en) | 2000-02-10 |
EP1100463B1 (en) | 2002-09-11 |
DE69902925T2 (de) | 2003-01-09 |
EP0976394A1 (en) | 2000-02-02 |
US6720305B1 (en) | 2004-04-13 |
EP1100463A1 (en) | 2001-05-23 |
JP2002521422A (ja) | 2002-07-16 |
DK1100463T3 (da) | 2003-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
KR870005637A (ko) | 약물 데포 | |
HUP9901144A2 (hu) | Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények | |
BR0111126A (pt) | Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos | |
ATE148630T1 (de) | Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen | |
PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
BR9912694A (pt) | Composto para preparar medicamento de administração pulmonar | |
DE69418468D1 (de) | Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen | |
BR9810495A (pt) | Composição farmacêutica | |
AR021370A1 (es) | Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides | |
DE69521693D1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
BR0210744A (pt) | Combinação farmacêutica sinergìstica para a prevenção ou tratamento de diabetes | |
KR960006915A (ko) | 췌장염의 치료 조성물 | |
PH27446A (en) | Compound with gastric acid inhibitory effect | |
EA199901012A1 (ru) | Фармацевтические композиции на основе тизоксанида и нитазоксанида | |
ES2179667T3 (es) | Nuevas formulaciones inyectables que contienen ramoplanina. | |
MX9203361A (es) | Composiciones farmaceuticas que contienen cloruro de galio. | |
SE9403137D0 (sv) | Derivatives of carbohydrates and compositions containing them | |
BR9807444A (pt) | Produto antimicrobial | |
SE8403659D0 (sv) | Synergistic pharmaceutical composition | |
DK0722325T3 (da) | Præparat til behandling eller forebyggelse af herpes | |
ES2128353T3 (es) | Composicion topica que contiene penciclovir. | |
KR890001540A (ko) | 심부전증 치료제 | |
ATE169819T1 (de) | (-)-metrifonat enthaltendes arzneimittel | |
KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 |